This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: National Taiwan Normal University, O2 Micro, Incorporated. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2019
Title: Innovations and Contributions of Yi-Ren Wang
Introduction
Yi-Ren Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the fields of medical treatment and power systems, holding two patents that showcase his innovative spirit and technical expertise.
Latest Patents
Yi-Ren Wang's latest patents include a method for preventing polycystic kidney disease (PKD) and advancements in power systems with platform-based controllers. The first patent discloses a method of treating or preventing PKD through the administration of neutrophil gelatinase-associated lipocalin (Ngal) protein. Additionally, a transgenic non-human animal model has been established to investigate the effects of overexpression of exogenous Ngal on PKD progression. The second patent describes a power system that includes a switching circuit, a resonant tank, a feedback circuit, and controller circuitry. This innovative power system is designed to control the power to a load effectively.
Career Highlights
Throughout his career, Yi-Ren Wang has worked with esteemed organizations such as National Taiwan Normal University and O2 Micro, Incorporated. His experience in these institutions has allowed him to develop and refine his inventions, contributing to advancements in technology and healthcare.
Collaborations
Yi-Ren Wang has collaborated with notable colleagues, including Hsiu-Mei Hsieh and Si-Tse Jiang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yi-Ren Wang's contributions to the fields of medicine and power systems highlight his role as a significant inventor. His patents reflect a commitment to improving health outcomes and advancing technology. His work continues to inspire future innovations in these critical areas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
